Safety Study of HRS-5765 in Healthy Adults
Part of Heart & circulation clinical trials.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You weigh between 50–90 kg (men) or 45–90 kg (women) with a healthy BMI
- You have no serious medical conditions or recent major illnesses, infections, or surgeries
- You have not donated blood or had a transfusion in the last 3–4 months
- You have not used recreational drugs and will not smoke during the study
- You are willing to use effective birth control (if fertile) until one week after your last dose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study of an experimental drug called HRS-7156 in people with no serious health conditions. Researchers will monitor how your body tolerates the drug and how it moves through your system.
This trial tests an oral drug called HRS-7535 for people with a certain type of heart failure (where the heart pumps normally but doesn't relax properly) and who also have obesity. It aims to see if the drug can improve symptoms and daily function.
This trial tests a new medicine called HRS-4029 in healthy people to see how safe it is and how the body handles it. It is an early-stage study that may help in developing a treatment for future patients.
This study tests the safety of a new oral medication called HRS-1597 in two groups: healthy people with normal weight and people who are overweight or obese. It will help determine if the drug is safe and how the body processes it.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This study tests a new investigational drug, called HRS-8797, in healthy people to see how safe it is and how the body processes it. It's an early-phase trial, so you may not directly benefit, but your participation can help find new treatments for future patients.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.